Human U87 Glioblastoma Cells With Stemness Features Display Enhanced Sensitivity to Natural Killer Cell Cytotoxicity Through Altered Expression of NKG2D Ligand

Cancer Cell International - United Kingdom
doi 10.1186/s12935-017-0397-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cytotoxicity of Natural Killer Cells Activated Through NKG2D Contributes to the Development of Bronchiolitis Obliterans in a Murine Heterotopic Tracheal Transplant Model

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2017English

Epirubicin Sequential Natural Killer Cells Enhanced the Cytotoxicity to Breast Cancer Cells in Vitro

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Human microRNA-1245 Down-Regulates the NKG2D Receptor in Natural Killer Cells and Impairs NKG2D-mediated Functions

Haematologica
Hematology
2012English

Human and Murine Inhibitory Natural Killer Cell Receptors Transfer From Natural Killer Cells to Target Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2004English

Granule-Dependent Natural Killer Cell Cytotoxicity to Fungal Pathogens

Frontiers in Immunology
AllergyImmunology
2017English

Chemotherapy-Induced Genotoxic Stress Promotes Sensitivity to Natural Killer Cell Cytotoxicity by Enabling Missing-Self Recognition

Cancer Research
Cancer ResearchOncology
2010English

Adaptive Immune Features of Natural Killer Cells

Nature
Multidisciplinary
2009English

NK Cell-Mediated Anti-Leukemia Cytotoxicity Is Enhanced Using a NKG2D Ligand MICA and Anti-Cd20 SCFV Chimeric Protein

European Journal of Immunology
AllergyImmunology
2018English

Lauryl Gallate Induces Apoptotic Cell Death Through Caspase-Dependent Pathway in U87 Human Glioblastoma CellsIn Vitro

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy